A New Deal for Pharma? Why the Washington Climate is Better Than it Looks
This article was originally published in RPM Report
Executive Summary
PhRMA's willingness to "share the pain" on health care reform leaves industry's investors howling. But-at least on paper-this deal looks like a great outcome for industry. If it holds.